Improving Access to Safe Medicines Act of 2022
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sep 22, 2022
Referred to the Subcommittee on Health.
Sep 21, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 21, 2022
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Improving Access to Safe Medicines Act of 2022
This bill requires the Drug Enforcement Administration to issue a proposed rule to remove a drug from scheduling under the Controlled Substances Act within 180 days of a recommendation from the Food and Drug Administration to do so.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
4
Cosponsors
1
Cite this page
U.S. Congress. (2026). H.R. 8931: Improving Access to Safe Medicines Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8931/
"H.R. 8931: Improving Access to Safe Medicines Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8931/.
H.R. 8931, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8931/.
[H.R. 8931: Improving Access to Safe Medicines Act of 2022](https://openamerica.io/bill/117-HR-8931/)